Literature DB >> 19482688

The role of FGF-2 in renal fibrogenesis.

Frank Strutz1.   

Abstract

Basic fibroblast growth factor (FGF-2) is a pleiotropic cytokine which exerts its effects via four different high affinity receptors (FGFR-1 to -4) which function as protein tyrosine kinases. In the kidney, FGF-2 is expressed in epithelial cells already during fetal development. During later stages, expression of the cytokine can be found in distal tubular epithelial cells, glomerular cells and few interstitial cells. Expression in fibroblasts is robustly upregulated in chronic kidney scarring pointing to an important role in fibrogenesis. Functional studies have demonstrated that FGF-2 exerts mainly proliferative effects on a variety of renal cell types. In regard to fibrogenesis, the expression and induction of proliferation in interstitial fibroblasts may be the most important function. FGF-2 is one of the key factors contributing to autocrine fibroblast proliferation in post-inflammatory matrix synthesis. In addition, FGF-2 facilitates epithelial to mesenchymal transition of tubular epithelial cells contributing early to an increase of matrix producing cells. However, the cytokine does not contribute directly to extracellular matrix synthesis. Still, many aspects of FGF-2 in renal fibrogenesis remains to be evaluated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482688     DOI: 10.2741/S12

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  11 in total

1.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

Review 2.  Fibroblasts and myofibroblasts in renal fibrosis.

Authors:  Soma Meran; Robert Steadman
Journal:  Int J Exp Pathol       Date:  2011-02-28       Impact factor: 1.925

3.  Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.

Authors:  Motoyuki Kumagai; Akira Marui; Yasuhiko Tabata; Takahide Takeda; Masaya Yamamoto; Atsushi Yonezawa; Shiro Tanaka; Shigeki Yanagi; Toshiko Ito-Ihara; Takafumi Ikeda; Toshinori Murayama; Satoshi Teramukai; Toshiya Katsura; Kazuo Matsubara; Koji Kawakami; Masayuki Yokode; Akira Shimizu; Ryuzo Sakata
Journal:  Heart Vessels       Date:  2015-04-11       Impact factor: 2.037

4.  FGF/FGFR2 Protects against Tubular Cell Death and Acute Kidney Injury Involving Erk1/2 Signaling Activation.

Authors:  Zhuo Xu; Xingwen Zhu; Mingjie Wang; Yibing Lu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2020-02-07

5.  Recapitulation of fibromatosis nodule by multipotential stem cells in immunodeficient mice.

Authors:  Jung-Pan Wang; Yun-Ju Hui; Shih-Tien Wang; Hsiang-Hsuan Michael Yu; Yi-Chao Huang; En-Rung Chiang; Chien-Lin Liu; Tain-Hsiung Chen; Shih-Chieh Hung
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

6.  Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice.

Authors:  Mariko Kamata; Hideki Amano; Yoshiya Ito; Tomoe Fujita; Fumisato Otaka; Kanako Hosono; Kouju Kamata; Yasuo Takeuchi; Takehiko Yokomizo; Takao Shimizu; Masataka Majima
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

Review 7.  Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion.

Authors:  Lian-Cheng Deng; Tahereh Alinejad; Saverio Bellusci; Jin-San Zhang
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

8.  Ablation of FGFR2 in Fibroblasts Ameliorates Kidney Fibrosis after Ischemia/Reperfusion Injury in Mice.

Authors:  Zhuo Xu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2017-11-16

9.  Renal Effects of Fetal Reprogramming With Pentaerythritol Tetranitrate in Spontaneously Hypertensive Rats.

Authors:  Andy W C Man; Min Chen; Zhixiong Wu; Gisela Reifenberg; Andreas Daiber; Thomas Münzel; Ning Xia; Huige Li
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

10.  Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.

Authors:  Yuting Chen; Qi Yan; Mengyue Lv; Kaixin Song; Yue Dai; Yi Huang; Le Zhang; Cuntai Zhang; Hongyu Gao
Journal:  Cell Death Dis       Date:  2020-11-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.